THE European Medicines Agency
has published a revised module
on “the Good Pharmacovigilance
Practices (GVP) on risk
management systems,” with a
public consultation now open for
submissions until 31 May.
It’s the first major revision of the
GVP since its 2012 launch, and is
based on experience gained since
the EMA’s Pharmacovigilance Risk
Committee started its operations.
Changes include clarification of
the activities a risk management
plan should focus on during the
life cycle of a product, ensuring
that “planning of activities directs
resources to areas where the need
for additional information and risk
minimisation is greatest”.
See ema.europa.eu for details.The above article was sent to subscribers in Pharmacy Daily's issue from 02 Mar 16 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 02 Mar 16
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.